---
title: "Clinical data of COVID-19 infected patients"
format: 
  revealjs:
    transition: none # Global default
editor: visual
subtite: "A case of study for critically ill patients"
css: styles.css
---

# Introduction {background-image="background.avif"}

(igual aqui habria que poner los nombres o algo supongo)

## Introduction

### Paxlovid and drugs

# Dataset

## Dataset

Quick overview fail, no se como exportar las table 1 para ponerlos aqui

```{r, echo=FALSE, results='asis'}
#library (grid)

#img <- png::readPNG("../results/table1_describe_01.png")
#grid::grid.raster(img)
```

```{r, echo=FALSE, results='asis'}
library(tidyverse)
library(knitr)

knit("../R/04_describe.qmd")
```

## Dataset 

::: {.column width="40%"}
<iframe src="../results/table1_describe_01.html" width="100%" height="400"></iframe>
:::


------------------------------------------------------------------------

# Results

------------------------------------------------------------------------

## Initial Exploration

In this section, we examine [key variables]{.fragment .highlight-red} to identify patterns and trends related to patient outcomes.

::: nonincremental
-   Age Groups
-   Antiviral Drug Administered
-   Symptoms and Diseases
-   CT Severity Scores
-   Early Onset Temperature
:::

------------------------------------------------------------------------

## Age Groups

::: columns
::: {.column width="60%"}
Mortality increases significantly with age, particularly amongst patients [older than 80]{.fragment .highlight-red}.

\

**Potential Impact**\
Older patients are at a higher risk, suggesting the importance of early and intensive monitoring for this group.
:::

::: {.column width="40%"}
<figure>

![Age vs. Patient Outcome](images/05_key_plot_1.png)

</figure>
:::
:::

------------------------------------------------------------------------

### Antiviral Drug Administration and Patient Outcome

::: columns
::: {.column width="60%"}
[Treated patients]{.fragment .highlight-red} show lower mortality rates, indicating their effectiveness in managing severe COVID-19 cases.

\

**Potential Impact**\
Timely administration of antiviral drugs could be crucial in mitigating severe outcomes, particularly in patients with high-risk profiles.
:::

::: {.column width="40%"}
<figure>

![Antiviral Drug vs Patient Outcome](images/05_key_plot_3.png)

</figure>
:::
:::

------------------------------------------------------------------------

### Symptoms, Comorbidities, and Mortality

#### Symptoms

::: columns
::: {.column width="60%"}
The most common symptoms [Respiratory & Whole Body]{.fragment .highlight-red}, display an equal split.

\

Less common symptoms [Gastrointestinal, Nervous & Other]{.fragment .highlight-red}, appear with high negative outcomes.
:::

::: {.column width="40%"}
<figure>

![Symptoms vs. Mortality Rate](images/05_key_plot_4.png)

</figure>
:::
:::

------------------------------------------------------------------------

### Symptoms, Comorbidities, and Mortality

#### Diseases

::: columns
::: {.column width="60%"}
Underlying diseases such as [Diabetes, Hypertension, & Cardiovascular disease]{.fragment .highlight-red} are linked to a higher risk of mortality.

\

**Potential Impact**\
Patients with these comorbidities may require tailored care and closer monitoring to improve outcomes.
:::

::: {.column width="40%"}
<figure>

![Diseases vs. Mortality Rate](images/05_key_plot_5.png)

</figure>
:::
:::

------------------------------------------------------------------------

### CT Severity Scores and Mortality

::: aside
CT scans were performed in a progressive manner, to monitor the development of patients' conditions.
:::

::: columns
::: {.column width="60%"}
::: nonincremental
[Higher CTSS]{.fragment .highlight-red} - indicating extensive lung damage, are associated with increased mortality.
:::

\

**Potential Impact**\
CT scans can serve as a critical tool for identifying patients who may need more aggressive treatment and care.
:::

::: {.column width="40%"}
<figure>

![CT Severity Scores vs. Mortality Rate](images/05_key_plot_6.png)

</figure>
:::
:::

------------------------------------------------------------------------

### Early Onset Temperature and Mortality

::: columns
::: {.column width="50%"}
[Elevated EOT]{.fragment .highlight-red} correlate with higher mortality rates, suggesting the need for prompt temperature management.

\

**Potential Impact**\
Effective fever management could be a key component in improving patient outcomes.
:::

::: {.column width="50%"}
<figure>

![Early Onset Temperature vs. Patient Outcome](results/05_key_plot_7.png)

</figure>
:::
:::

------------------------------------------------------------------------

### Summary of Initial Findings

\

::: incremental
**Overarching Patterns**:

Demographic vulnerability, significant impact of comorbidities and symptoms, treatment efficacy, and severity scores.\

\
**Strategic Takeaways**:

Targeted interventions are crucial for specific demographics, early antiviral treatment, and managing patients with severe symptoms or high CT scores.
:::

# Analysis {.transition-fade}

## Analysis {.transition-fade}

::: incremental
-   Initial exploration: What factors we think might be related to the outcome?
-   Statistical exploration: What factors are statistically related to the outcome?
-   Paxlovid exploration: Can we get the same result as the main paper with this data?
:::

## Analysis - Initial exploration of the Data

::: nonincremental
-   ::: nonincremental
    In this section, we examine key variables to identify patterns and trends related to patient outcomes.
    :::
:::

## Analysis - Initial exploration

::: nonincremental
-   In this section, we examine key variables to identify patterns and trends related to patient outcomes.
    -   Age Range
    -   Antiviral Drug Administered
    -   Symptoms and Diseases
    -   CT Severity Scores
    -   Early Onset Temperature
:::

## Analysis - Initial exploration

What factors we think might be related to the outcome?

## Analysis - Statistical exploration

What factors are statistically related to the outcome?

```{r}
library(tidyverse)
#library(knitr)

load("../results/significant_variables.RData")
significant_variables_direct_corr <- significant_variables |> 
  arrange(desc(estimate))

significant_variables_inverse_corr <- significant_variables |> 
  arrange(estimate)

#kable(significant_variables_direct_corr, caption = "Tabla de Estimaciones")
head(significant_variables_direct_corr, n=10)
#head(significant_variables_inverse_corr)
```

## Analysis - Statistical exploration

What factors are statistically related to the outcome?

```{r}
library(tidyverse)
library(knitr)

#kable(significant_variables_direct_corr, caption = "Tabla de Estimaciones")
head(significant_variables_inverse_corr, n=10)
#head(significant_variables_inverse_corr)
```

## Analysis - Statistical exploration

Variables with direct correlation

## Analysis - Statistical exploration

Variables with inverse correlation

por aqui tendria pensado poner lo del analisis quitando a la gente con sangradosss, y que nos de pie a explicar todo el tema de la trombosis y tal

## Analysis - Paxoliv exploration

results about paxlovid?
